Two arrests after Palestine Action claims blocking Israeli defence firm UK site
Avon and Somerset Police said a 30-year-old woman and a 36-year-old man, both from London, have been arrested on suspicion of criminal damage, unauthorised entry to a prohibited place and locking onto a person, object or land to cause serious disruption.
Earlier on Tuesday, a Palestine Action spokesperson said activists had blocked the entrance to Elbit Systems in Bristol, and covered it in red paint 'to symbolise Palestinian bloodshed'.
Avon and Somerset Police said officers were called to the site at around 6.30am.
A spokeswoman said: 'Two people have been arrested following a small protest outside a premises at the Aztec West Business Park, in Almondsbury.
'They remain in police custody and inquiries are ongoing.
'We're committed to facilitating people's right to peaceful protest, but will not tolerate any criminal behaviour.'
The incident comes as a draft order was laid before Parliament on Monday to amend the Terrorism Act 2000 to include Palestine Action as a proscribed organisation.
If approved, it would become a criminal offence punishable by up to 14 years in prison to be a member of the direct action group or to support it.
MPs and peers are expected to debate the legislation on Wednesday and Thursday and, if approved, the ban could come into force by Friday.
A Palestine Action spokesperson said: 'While the Government is rushing through Parliament absurd legislation to proscribe Palestine Action, the real terrorism is being committed in Gaza.
'Palestine Action affirms that direct action is necessary in the face of Israel's ongoing crimes against humanity of genocide, apartheid, and occupation, and to end British facilitation of those crimes.'
The group also occupied the rooftop of UK subcontractor Guardtech Group, the spokesperson added.
Officers are also at the scene at the site in Brandon, Suffolk.
A Suffolk Police spokesman said: 'Officers and specialist negotiators are currently at the location and our immediate priority is to bring this to a conclusion and to ensure the safety of everyone at the scene.'
Palestine Action is seeking a legal challenge against the Government's bid to proscribe it, with a hearing expected on Friday to decide whether the ban can be temporarily blocked, pending further proceedings to decide whether a legal challenge can be brought.
Commenting on the proscription on Monday, Home Secretary Yvette Cooper said: 'The right to protest and the right to free speech are the cornerstone of our democracy and there are countless campaign groups that freely exercise those rights.
'Violence and serious criminal damage has no place in legitimate protests.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Guardian
18 minutes ago
- South Wales Guardian
Chief executive of miscarriage of justice review body resigns
Karen Kneller, who had held the position since 2013, has left her job at the Criminal Cases Review Commission (CCRC), it was announced on Wednesday. Last month former victims Commissioner Dame Vera Baird became the interim chairwoman of the CCRC, having been asked by the Lord Chancellor to carry out a review of the organisation. The CCRC had been heavily criticised for its handling of the Andrew Malkinson case, one of the worst miscarriages of justice in British legal history. Ms Kneller's resignation came after former chairwoman Helen Pitcher resigned in January, but claimed she had been scapegoated over the Malkinson case. Dame Vera said: 'The CCRC has a vital role to play in the criminal justice system, but confidence in the organisation has been badly damaged. Confidence in our work must be restored. 'I thank Karen for her work at the CCRC over many years.' Amanda Pearce, who is CCRC casework operations director, has been appointed interim chief executive. Mr Malkinson served 17 years in prison for a rape he did not commit, and was knocked back twice by the CCRC until his legal team carried out crucial DNA testing that was then repeated by the commission and led to his release. A review found that he could have been released 10 years earlier if the CCRC had obtained new DNA evidence as early as 2009, and thousands of cases are being reviewed in the wake of the bungled handling of the case. In May, the Commons Justice Committee also warned that the position of the current chief executive of the CCRC, Karen Kneller, was no longer tenable. MPs said in a report it followed 'unpersuasive' evidence from her on the CCRC's challenges and response to public criticisms in April, and concerns on the performance of the review body.
North Wales Chronicle
30 minutes ago
- North Wales Chronicle
Chief executive of miscarriage of justice review body resigns
Karen Kneller, who had held the position since 2013, has left her job at the Criminal Cases Review Commission (CCRC), it was announced on Wednesday. Last month former victims Commissioner Dame Vera Baird became the interim chairwoman of the CCRC, having been asked by the Lord Chancellor to carry out a review of the organisation. The CCRC had been heavily criticised for its handling of the Andrew Malkinson case, one of the worst miscarriages of justice in British legal history. Ms Kneller's resignation came after former chairwoman Helen Pitcher resigned in January, but claimed she had been scapegoated over the Malkinson case. Dame Vera said: 'The CCRC has a vital role to play in the criminal justice system, but confidence in the organisation has been badly damaged. Confidence in our work must be restored. 'I thank Karen for her work at the CCRC over many years.' Amanda Pearce, who is CCRC casework operations director, has been appointed interim chief executive. Mr Malkinson served 17 years in prison for a rape he did not commit, and was knocked back twice by the CCRC until his legal team carried out crucial DNA testing that was then repeated by the commission and led to his release. A review found that he could have been released 10 years earlier if the CCRC had obtained new DNA evidence as early as 2009, and thousands of cases are being reviewed in the wake of the bungled handling of the case. In May, the Commons Justice Committee also warned that the position of the current chief executive of the CCRC, Karen Kneller, was no longer tenable. MPs said in a report it followed 'unpersuasive' evidence from her on the CCRC's challenges and response to public criticisms in April, and concerns on the performance of the review body.
Spectator
40 minutes ago
- Spectator
If AstraZeneca quits the London Stock Exchange, it will be a disaster
It was already a bad enough week for the Prime Minister Sir Keir Starmer and the Chancellor Rachel Reeves, what with the collapse of their welfare reforms. But now news has leaked that AstraZeneca's CEO Sir Pascal Soriot has reportedly discussed moving its listing from London to New York. There is nothing official yet, and no decision has been made. But for the boss of Britain's most valuable listed company to even contemplate upping sticks spells trouble for the UK economy. It is not hard to blame him. Over-regulation has turned the London market into a relative backwater. Meanwhile, Wall Street has been booming. The business would be more highly valued on the other side of the Atlantic. US president Donald Trump wants the pharma industry to invest more in the United States – given that sky-high drug prices fuel its profits – and a Wall Street listing would help that. Back in Britain, corporate taxes have already been pushed up sharply, and look likely to go up again over the next few years as the government struggles to pay for the juggernaut of welfare spending. For a successful global business, it is hard to see the point of listing in a small, stagnant economy when it would be warmly welcomed on a far bigger stage. If AstraZeneca does depart Britain, the London stock market – and the government would be in hot water. AstraZeneca is the FTSE 100's largest company, and one of the UK's most successful firms. The government has put life sciences at the core of its industrial strategy, and it remains one of the few industries where the UK is clearly a global leader. Even worse, its departure would send a clear message to other multinationals around the world that it was not worth the bother of investing in Britain, and it would encourage others to leave as well. It would be hard to imagine that GSK would stick around for long. Or Unilever. Or the mining giant Rio Tinto, or HSBC or Diageo. One by one, they would all list their shares in New York, and once they had made that move their headquarters would quickly move as well. In reality, the government has been far too complacent both about persuading companies to invest in the UK, and about making the London stock market more competitive. Chancellor Rachel Reeves inherited a crisis, but she has so far only managed to make it worse. If AstraZeneca leaves, it will be too late to stop the exodus – and the British economy will be in big trouble.
